Jobs / United States / Abbvie INC
Principal Scientist II, Analytical Platform Sciences and Characterization, tLNP
Abbvie INC · 🇺🇸 North Chicago, IL, US
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Abbvie INC paid sponsored hires in similar roles3 certified filings for “Senior Scientist II Formulation Sciences” (Chemical Engineers) in IL: $134k–$160k, median $139k. Most were filed at wage level III (67%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Abbvie INC
The US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Abbvie INC →
About the role
The Analytical Development group within the Targeted LNP (tLNP) CMC Team at AbbVie is dedicated to advancing state-of-the-art analytical capabilities for mRNA-lipid nanoparticle therapeutics. Our team provides critical support across drug substance (DS) and drug product (DP) manufacturing, drug product formulation, and the development and implementation of robust analytical methodologies to ensure the quality and integrity of tLNP genetic medicines. We leverage advanced biophysical, separations, and mass spectrometry techniques to deeply characterize intact LNP particles. We foster close collaborations with cross-functional colleagues in CMC, drug product formulation, and external partners, and are currently growing a world-class team of scientists who will be instrumental in building and deploying the analytical toolbox necessary to deliver high-quality, innovative tLNP medicines to patients. Position Description: The Analytical Research & Development group within Targeted Lipid Nanoparticle (tLNP) CMC Team is responsible for building the scientific capabilities that will enable the next generation of genetic medicines. Our team advances innovative analytical approaches that deepen mechanistic understanding of tLNP systems, accelerate development decisions, and create differentiated platform capabilities across AbbVie's expanding nucleic acid therapeutic portfolio. We are seeking an exceptional scientific leader to serve as Principal Scientist II/Associate Director of Analytical Platform Sciences & Characterization, leading a multidisciplinary team responsible for advanced characterization, platform science, mechanistic understanding, emerging analytical technologies, and analytical innovation. This individual will drive the development and application of next-generation analytical capabilities spanning particle characterization, structure-function understanding, mass spectrometry, advanced biophysical characterization, data analytics, and other enabling technologies critical to the advancement of tLNP therapeutics. The successful candidate will partner closely with tLNP Drug Product Development, tLNP Process Development, Discovery, Quality, Regulatory Affairs, and cross-functional CMC teams to convert analytical observations into actionable scientific insights. In addition to serving as a recognized scientific expert, the individual will lead and develop scientists, establish strategic capability roadmaps, foster external scientific collaborations, and help shape the future direction of analytical science within AbbVie's tLNP CMC organization. This position represents a unique opportunity to build and lead a growing scientific organization at the intersection of analytical chemistry, nanomedicine, biologics characterization, and genetic medicine development. Beyond technical excellence, the role requires strong organizational leadership, talent development, strategic thinking, and the ability to influence scientific direction across multiple programs and platforms. The selected candidate will report directly to the Director of tLNP Analytical R&D and will play a key role in developing the scientific capabilities, organizational strength, and leadership pipeline needed to support AbbVie's long-term ambitions in genetic medicines. Key Responsibilities: Scientific & Technical Leadership • Establish and execute the scientific strategy for the Analytical Platform Sciences & Characterization organization, advancing mechanistic understanding of tLNP systems and enabling improved development decisions. • Drive the development and application of advanced analytical technologies and characterization approaches to support AbbVie's genetic medicines portfolio. • Identify emerging scientific trends, technologies, and opportunities and tr